Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Invested Capital (2022)

Historic Return on Invested Capital for Cullinan Therapeutics (CGEM) over the last 2 years, with Q3 2023 value amounting to 0.36%.

  • Cullinan Therapeutics' Return on Invested Capital fell 5300.0% to 0.36% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.36%, marking a year-over-year decrease of 5300.0%. This contributed to the annual value of 0.22% for FY2022, which is N/A changed from last year.
  • As of Q3 2023, Cullinan Therapeutics' Return on Invested Capital stood at 0.36%, which was down 5300.0% from 0.32% recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Return on Invested Capital ranged from a high of 0.21% in Q2 2022 and a low of 0.36% during Q3 2023